Stressful life events and the risk of primary progressive multiple sclerosis: A population-based case-control study
Publication date: June 2021Source: Multiple Sclerosis and Related Disorders, Volume 51Author(s): Alimohammad Mohtasham Alsharie, Farnaz Rafiee, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi, Mohammad Ali Sahraian, Sharareh Eskandarieh (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - April 12, 2021 Category: Neurology Source Type: research

How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey
Publication date: June 2021Source: Multiple Sclerosis and Related Disorders, Volume 51Author(s): Elizabeth H. Morrison, Katelyn Michtich, Carrie M. Hersh (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - April 9, 2021 Category: Neurology Source Type: research

Use of cannabis in patients with multiple sclerosis from Argentina
Publication date: Available online 6 April 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Edgar Carnero Contentti, Pablo A. López, Juan Criniti, Juan Pablo Pettinicchi, Dario Tavolini, Carolina Mainella, Santiago Tizio, Verónica Tkachuk, Berenice Silva, Alejandro Caride, Juan I. Rojas, Ricardo Alonso (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - April 6, 2021 Category: Neurology Source Type: research

Failure of IVIG in Steroid-Responsive Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Case Report
Publication date: Available online 4 April 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Elena S. Heide, Amit Chaudhari, Ateena Pirverdian, Sam Lai, Ardith Courtney (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - April 5, 2021 Category: Neurology Source Type: research

Effects of low vs. high frequency local vibration on mild-moderate muscle spasticity: ultrasonographical and functional evaluation in patients with multiple sclerosis
Publication date: Available online 31 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Fatma Ayvat, Levent Özçakar, Ender Ayvat, Sibel Aksu Yıldırım, Muhammed Kılınç (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 31, 2021 Category: Neurology Source Type: research

Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnoses and monitoring progressive multiple sclerosis?
Publication date: Available online 31 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Kira Groen, Jeannette Lechner-Scott, Daniela Pohl, Michael Levy, Gavin Giovannoni, Chris Hawkes (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 31, 2021 Category: Neurology Source Type: research

Neutrophil-Lymphocyte Ratio as a marker for Disability and Activity in Multiple Sclerosis
Publication date: Available online 28 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Rasha M. Fahmi, Bothina M. Ramadan, Hanan Salah, Ahmed F. Elsaid, Nahed Shehta (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 29, 2021 Category: Neurology Source Type: research

Effects on gait and balance of home-based active video game interventions in persons with multiple sclerosis: a systematic review
Publication date: Available online 28 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Marion Dalmazane, Matthieu Gallou-Guyot, Maxence Compagnat, Laurent Magy, Alexis Montcuquet, Jean-Christophe Daviet, Anaick Perrochon (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 28, 2021 Category: Neurology Source Type: research

Atypical inflammatory demyelinating syndrome with central and peripheral nerve involvement
Publication date: Available online 26 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Mena Farag, Naomi Sibtain, James Burge, Vinay Chaudhry, Eli Silber (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 27, 2021 Category: Neurology Source Type: research

COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update
Publication date: Available online 27 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Dominic Jack, Doris Damian, Axel Nolting, Andrew Galazka (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 27, 2021 Category: Neurology Source Type: research

Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis
Publication date: Available online 27 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Fan Ge, Zhenyu Huo, Caichen Li, Runchen Wang, Rui Wang, Yeling Liu, Jiana Chen, Yi Lu, Yaokai Wen, Yu Jiang, Haoxin Peng, Xiangrong Wu, Hengrui Liang, Jianxing He, Wenhua Liang (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 27, 2021 Category: Neurology Source Type: research

Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia
Publication date: Available online 25 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Mohammed Al Jumah, Ahmad Abulaban, Hani Aggad, Reem Al Bunyan, Mona AlKhawajah, Yaser Al Malik, Mousa Almejally, Hind Alnajashi, Foziah Alshamrani, Saeed Bohlega, Edward J Cupler, Ahmed El Boghdady, Seraj Makkawi, Shireen Qureshi, Sahar Shami (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 26, 2021 Category: Neurology Source Type: research

Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
Publication date: Available online 25 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Gauruv Bose, Kristin Galetta (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 26, 2021 Category: Neurology Source Type: research

Middle-Age People with Multiple Sclerosis Demonstrate Similar Mobility Characteristics to Neurotypical Older Adults
Publication date: Available online 25 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Clayton W. Swanson, Sutton B. Richmond, Benjamin E. Sharp, Brett W. Fling (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 26, 2021 Category: Neurology Source Type: research

Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light
Publication date: Available online 24 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Gergely Orsi, Tamas Cseh, Zsofia Hayden, Gabor Perlaki, Szilvia Anett Nagy, Omar Giyab, Dorte Aalund Olsen, Jonna Skov Madsen, Timea Berki, Zsolt Illes (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 25, 2021 Category: Neurology Source Type: research

Recurrence of disease activity after fingolimod discontinuation in older patients previously stable on treatment.: All patients with FTY withdrawal(n=128)Age (y) at disease onset (mean, SD)32.4, 8.9Sex, F/M (n)94/34Positive OCB (%)95.6Prior treatment (n, %)Treatment naiveFirst lineNTZOther 2d line56/128, 43.8 %59/128, 46.1 %11/128, 8.6 %2/128, 1.6 %Disease activity prior to FTY initiation Highly active patients (n, %)26/128, 20.3 %Relapses (mean, SD) 1, 0.9EDSS (median, range)2, 1-6.5No of new T2 lesions (mean, SD)4.7, 10.2No of Gd enhancing lesions (mean, SD)1.7, 5.6NEDA-3 status on FTY treatment (n, %)73/128, 57 %Age (y) at FTY discontinuation (mean, SD)41.6, 11Treatment duration (months) (mean, SD)40.3, 25.3Wash out period (days) (mean, SD)59.5, 44.1Age at fingolimod discontinuationYounger patients(n=52)Older patients(n=21) P valueAge (y) at disease onset (mean, SD)31.1, 741.1, 8.4<0.001Age (y) at FTY discontinuation(mean, SD)38.4, 7.756.8, 5<0.001Prior treatment (n, %)Treatment naiveFirst linePrevious NTZCladribine25/52, 58.124/52, 46.22/52, 3.81/52, 1.94/21, 1914/21, 66.71/21, 4.81/21, 4.80.119Disease activity prior to FTY initiation(mean, SD)RelapsesEDSS (median, range)No of new T2 lesionsNo of Gd enhancing lesions0.9, 11.5, 1-6.53.5, 71, 2.30.5, 0.72, 1.5-6.51.9, 3.20.5, 1.20.1010.2170.2080.226Treatment duration (m), (mean, SD)37.6, 29.646.8, 20.20.131Wash-out period (days) (mean, SD)90.8, 6767.7, 29.20.138Disease activity after FTY discontinuation (mean, SD)RelapsesEDSS 0.3, 0.61,5, 0-80.1, 0.32.0, 1-6.50.0690.051No of new T2 lesionsNo of Gd enhancing lesions3.5, 8.62.8, 8.50.6, 1.80.4, 1.40.0710.101DMT relay (n, %)NoneIFNDMFTRFNTZAnti-CD2032/52, 61.53/52, 5.83/52, 5.89/52, 17.31/52, 1.94/52, 7.74/21, 1905/21, 23.89/21, 42.903/21,14.30.013
Publication date: Available online 21 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Vasiliki Pantazou, Caroline Pot, Renaud Du Pasquier, Géraldine Le Goff, Marie Théaudin (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 22, 2021 Category: Neurology Source Type: research

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
Publication date: Available online 20 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Masoud Etemadifar, Nahad Sedaghat, Ali Aghababaee, Parisa K Kargaran, Mohammad Reza Maracy, Mazdak Ganjalikhani-Hakemi, Milad Rayani, Amir Parsa Abhari, Reza Khorvash, Mehri Salari, Hosein Nouri (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 21, 2021 Category: Neurology Source Type: research

Spinal cord involvement in LHON requires pathophysiological clarification
Publication date: Available online 21 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): j Finsterer (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 21, 2021 Category: Neurology Source Type: research

Restless Legs Syndrome in Multiple Sclerosis: risk factors and effect on sleep quality – a case-control study
Publication date: Available online 21 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Tobias Monschein, Christian Schestak, Cornelia Schillerwein-Kral, Fritz Leutmezer, Thomas Berger, Gabriel Bsteh, Stefan Seidel (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 21, 2021 Category: Neurology Source Type: research

Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis
Publication date: Available online 21 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Duong T. Chu, Mattia Rosso, Cindy T. Gonzalez, Shrishti Saxena, Brian C. Healy, Howard L. Weiner, Tanuja Chitnis (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 21, 2021 Category: Neurology Source Type: research

COVID-19 and emerging spinal cord complications: A systematic review
Publication date: Available online 21 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Ritwick Mondal, Shramana Deb, Gourav Shome, Upasana Ganguly, Durjoy Lahiri, Julián Benito-Leon (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 21, 2021 Category: Neurology Source Type: research

Predominant cognitive phenotypes in multiple sclerosis: insights from patient-centered outcomes
Publication date: Available online 21 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Jessica Podda, Michela Ponzio, Ludovico Pedullà, Margherita Monti Bragadin, Mario Alberto Battaglia, Paola Zaratin, Giampaolo Brichetto, Andrea Tacchino (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 21, 2021 Category: Neurology Source Type: research

A mixed-methods study of cognitive performance in persons with multiple sclerosis: Association between neuropsychological test performance and interviews about daily cognitive functioning
Publication date: Available online 19 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Nadine Akbar, Marcia Finlayson (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 20, 2021 Category: Neurology Source Type: research

Low-field Portable Brain MRI in CNS Demyelinating Disease
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Farrah J. Mateen, Clarissa Zimmerman Cooley, Jason P. Stockmann, Dylan R. Rice, Andre C. Vogel, Lawrence L. Wald (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 19, 2021 Category: Neurology Source Type: research

Rabies vaccination and multiple sclerosis relapse: a retrospective cohort study
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Angela Huttner, Agustina M. Lascano, Serge Roth, Jean-Marc Schwob, Gilles Eperon, Claire-Anne Siegrist, Patrice H. Lalive (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 19, 2021 Category: Neurology Source Type: research

Rituximab for refractory Primary Angiitis of the Central Nervous System: Experience in two patients
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Naveen Kumar Paramasivan, Soumya Sundaram, Dev Prakash Sharma, Sapna Erat Sreedharan, PN Sylaja (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 19, 2021 Category: Neurology Source Type: research

Comparative effectiveness of psychotherapy approaches on Death Anxiety in Multiple Sclerosis Patients. A pilot randomized controlled trial
Publication date: Available online 19 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Behnam Lotfifar, Ezatolah Ghadampour, Nasrin Bagheri (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 19, 2021 Category: Neurology Source Type: research

Alemtuzumab in Covid era
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Aniello Iovino, Nunzio Olivieri, Francesco Aruta, Emanuele Giaquinto, Lucia Ruggiero, Emanuele Spina, Stefano Tozza, Fiore Manganelli, Rosa Iodice (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 18, 2021 Category: Neurology Source Type: research

Results of a Nationwide Provider Survey
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Elizabeth H. Morrison, Katelyn Michtich, Carrie M. Hersh (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 18, 2021 Category: Neurology Source Type: research

Integrating patient-reported outcomes and quantitative timed tasks to identify relapsing remitting multiple sclerosis patient subgroups: a latent profile analysis
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Farren B.S. Briggs, Devon S. Conway, Alessandro S. De Nadai, Daniel Ontaneda, Douglas D. Gunzler (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 18, 2021 Category: Neurology Source Type: research

Use of geographical information systems in multiple sclerosis research: A systematic scoping review
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Soheil Hashtarkhani, Hossein Tabatabaei-Jafari, Behzad Kiani, MaryAnne Furst, Luis Salvador-Carulla, Nasser Bagheri (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 18, 2021 Category: Neurology Source Type: research

Do baseline cognitive status, participant specific characteristics and EDSS impact changes of cognitive performance following aerobic exercise intervention in multiple sclerosis?
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Annette Rademacher, Niklas Joisten, Sebastian Proschinger, Jonas Hebchen, Marit Lea Schlagheck, Wilhelm Bloch, Roman Gonzenbach, Jan Kool, Jens Bansi, Philipp Zimmer (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 18, 2021 Category: Neurology Source Type: research

Depression in multiple sclerosis: Is one approach for its management enough?
Publication date: Available online 18 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): C. Danielle Jones, Robert Motl, Brian M. Sandroff (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 18, 2021 Category: Neurology Source Type: research

Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series
Publication date: Available online 13 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Nurhan Kaya Tutar, Sami Omerhoca, Eda Coban, Nilufer Kale (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 13, 2021 Category: Neurology Source Type: research

A case of longitudinally extensive transverse myelitis in an 80-year-old patient with systemic lupus erythematous and anti-aquaporin 4 antibodies
Publication date: Available online 13 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): F. Pirro, V. Mantero, A. Rigamonti, C. Scaccabarozzi, U. Pozzetti, R. Balgera, A. Salmaggi (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 13, 2021 Category: Neurology Source Type: research

Corpus Callosum Lesions are not Inextricably Linked to CNS Symptoms in Reported Cases of Susac Syndrome
Publication date: Available online 10 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Gillian R Paton, Claire Sheldon, Talia Vertinsky, Eduardo Navajas, Anthony Traboulsee, Mollie Carruthers, Robert Carruthers (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 11, 2021 Category: Neurology Source Type: research

Serotoninergic system targeting in multiple sclerosis: the prospective for pathogenetic therapy.
Publication date: Available online 10 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Mikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, Alexander Oleskin, Marina Boziki, Christos Bakirtzis, Evangelia Kesidou, Nikolaos Grigoriadis, Alexey Boykо (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 11, 2021 Category: Neurology Source Type: research

MS and Disability Progression in Latin America, Africa, Asia and the Middle East: A Systematic Review
Publication date: Available online 9 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Samuele Bonomi, Shan Jin, William J. Culpepper, Mitchell T. Wallin (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 10, 2021 Category: Neurology Source Type: research

Myelin oligodendrocyte glycoprotein antibody-associated disorders coexisting with ankylosing spondylitis: potential association between demyelination and tumor necrosis factor inhibitors
Publication date: Available online 10 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Wenjng Luo, Rui Li, Yanyu Chang, Hongda She, Allan G Kermode, Wei Qiu (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 10, 2021 Category: Neurology Source Type: research

B cell therapy and the use of RNA-based COVID-19 vaccines
Publication date: Available online 8 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Anastasia Vishnevetsky, Chris Hawkes, Jeannette Lechner-Scott, Gavin Giovannoni, Michael Levy (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 9, 2021 Category: Neurology Source Type: research

Underutilization of Contraception in Young Females with Demyelinating Disorders
Publication date: Available online 9 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Jonathan D. Santoro, Brigitte Hurtubise, Justin Del Rosario, Dania Pagarkar, Sarah E. Wiegand, Elaine Su, Nusrat Ahsan (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 9, 2021 Category: Neurology Source Type: research

Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy
Publication date: June 2021Source: Multiple Sclerosis and Related Disorders, Volume 51Author(s): M. Jonakowski, I. Kuprys-Lipinska, P. Lacwik, M. Stasiolek, M. Matysiak (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 9, 2021 Category: Neurology Source Type: research

A Pharmacokinetic and Biomarker Study of Delayed-Release Dimethyl Fumarate in Subjects with Secondary Progressive Multiple Sclerosis: Evaluation of Cerebrospinal Fluid Penetration and the Effects on Exploratory Biomarkers
Publication date: Available online 24 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Keith R. Edwards, Aneesh Kamath, Judy Button, Vineetha Kamath, Jason P. Mendoza, Bing Zhu, Tatiana Plavina, Caroline Woodward, Natalia Penner (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
Publication date: Available online 25 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): MengJiao Sun, Ning Liu, QinFang Xie, Xiaoling Li, Jing Sun, Hongxia Wang, ManXia Wang (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

Effectiveness of Treatments in Neuromyelitis Optica to Modify the Course of Disease in Adult Patients. Systematic Review of Literature.
Publication date: Available online 25 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Mario Velasco, Luis Alfonso Zarco, Mariana Agudelo-Arrieta, Isabel Torres-Camacho, Elkin Garcia-Cifuentes, Oscar Muñoz (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

First report of HHV-8 viral load and seroprevalence of major blood-borne viruses in Iranian patients with systemic sclerosis
Publication date: Available online 28 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Ava Hashempour, Javad Moayedi, Zahra Musavi, Farzaneh Ghasabi, Mehrdad Halaji, Zahra Hasanshahi, Mohammad Ali Nazarinia (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy.
Publication date: Available online 28 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): M. Jonakowski, I. Kuprys-Lipinska, P. Lacwik, M. Stasiolek, M. Matysiak (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

The concurrence of multiple sclerosis and glioblastoma
Publication date: Available online 2 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Samir Alkabie, Rhaisa Castrodad-Molina, Kent A. Heck, Jacob Mandel, George J. Hutton (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

Rate, Burden, and Treatment of Sexual Dysfunction in Multiple Sclerosis: The Case for Exercise Training as a New Treatment Approach
Publication date: Available online 2 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Dena Sadeghi Bahmani, Robert W Motl (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research

“Peppering the Pons”: CLIPPERS or Myelin Oligodendrocyte Glycoprotein Associated Disease?
Publication date: Available online 2 March 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Ahmed Z. Obeidat, Allison N. Block, Sam I. Hooshmand (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - March 8, 2021 Category: Neurology Source Type: research